Taken together, these data suggest that 1NMPP1-mediated specific TrkA inhibition can reduce the IAV-induced lung inflammation independent of its direct antiviral activity, supporting a direct role of the TrkA signaling in the IAV-induced airway inflammation. The gene discussed is NTRK1; the disease is inflammatory response.